Legend Biotech Corporation engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for gastric cancer and T cell lymphoma.
| Market Cap | 9.874 Billion | Shares Outstanding | 165.067 Million | Avg 30-day Volume | 913.847 Thousand |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.43 |
| Price to Revenue | 140.8514 | Debt to Equity | 0.3775 | EBITDA | -433.075 Million |
| Price to Book Value | 22.1417 | Operating Margin | -399.87780000000004 | Enterprise Value | 15.79 Billion |
| Current Ratio | 3.691 | EPS Growth | 0 | Quick Ratio | 3.263 |
| 1 Yr BETA | 0.63 | 52-week High/Low | 77.32 / 42.91 | Profit Margin | -381.4786 |
| Operating Cash Flow Growth | 4753.7709 | Free Cash Flow to Firm (FCFF) TTM | -340.865 Million | Free Cash Flow to Equity (FCFE) TTM | |
| Altman Z-Score | 16.5606 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 19:45:03 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 19:15:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 18:45:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 18:15:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 17:45:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 17:15:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 16:45:03 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 16:15:04 UTC | 5.07 | 0.25 | 3900000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 15:45:04 UTC | 5.07 | 0.25 | 3900000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 15:15:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 14:45:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 14:15:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 13:45:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 13:15:04 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-30 12:45:03 UTC | 5.07 | 0.25 | 3800000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-29 22:15:05 UTC | 5.07 | 0.25 | 3900000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-29 21:45:04 UTC | 5.07 | 0.25 | 3900000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-29 21:15:05 UTC | 5.07 | 0.25 | 3900000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-29 20:45:04 UTC | 5.07 | 0.25 | 3900000 |
| LEGEND BIOTECH CORP-ADR LEGN | 2023-11-29 20:15:03 UTC | 5.07 | 0.25 | 3900000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
